Detroit CSI: Collaboration to Improve Outcomes in Cardiogenic Shock
Announced Wednesday, the Detroit Cardiogenic Shock Initiative (CSI) is an innovative collaboration between five hospital systems in metro Detroit with the goal of determining whether outcomes in cardiogenic shock can be improved by using Impella® as early as possible for patients in the shock spiral.
Led by Dr. Bill O’Neill of Henry Ford Health System, the initiative includes physicians from Henry Ford, Beaumont, Detroit Medical Center Heart Hospital, St. Joseph Mercy Health System and St. John Providence Ascension.
Partnering hospital systems use a defined protocol for early placement of Impella in patients in cardiogenic shock. Since July, initial results from a small sampling of 30 patients show survival rates have improved from 50% to 80%.
Dr. O’Neill will present these findings at the American College of Cardiology’s Annual Scientific Session in Washington, DC in March. ProtectedPCI.com will be covering sessions throughout ACC.17 so stay tuned.
Cardiogenic Shock Protocol
Hear From Dr. O'Neill on Impella heart pump
Clinical Dossier Cardiogenic Shock
To learn more about the Impella® platform of heart pumps, including important risk and safety information associated with the use of the devices, please visit: abiomed.com/important-safety-information